These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8738769)

  • 1. Displacement of valproic acid and carbamazepine from protein binding in normal and uremic sera by tolmetin, ibuprofen, and naproxen: presence of inhibitor in uremic serum that blocks valproic acid-naproxen interactions.
    Dasgupta A; Volk A
    Ther Drug Monit; 1996 Jun; 18(3):284-7. PubMed ID: 8738769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro displacement of phenytoin from protein binding by nonsteroidal antiinflammatory drugs tolmetin, ibuprofen, and naproxen in normal and uremic sera.
    Dasgupta A; Timmerman TG
    Ther Drug Monit; 1996 Feb; 18(1):97-9. PubMed ID: 8848829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced in vitro displacement of valproic acid from protein binding by salicylate in uremic sera compared with normal sera. Role of uremic compounds.
    Dasgupta A; Jacques M
    Am J Clin Pathol; 1994 Mar; 101(3):349-53. PubMed ID: 8135194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamazepine-salicylate interaction in normal and uremic sera: reduced interaction in uremic sera.
    Dasgupta A; Thompson WC
    Ther Drug Monit; 1995 Apr; 17(2):199-202. PubMed ID: 7624911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of valproic acid with nonsteroidal antiinflammatory drugs mefenamic acid and fenoprofen in normal and uremic sera: lack of interaction in uremic sera due to the presence of endogenous factors.
    Dasgupta A; Emerson L
    Ther Drug Monit; 1996 Dec; 18(6):654-9. PubMed ID: 8946661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid-ketoconazole interaction in normal, hypoalbuminemic, and uremic sera: lack of interaction in uremic serum caused by the presence of inhibitor.
    Dasgupta A; Luke M
    Ther Drug Monit; 1997 Jun; 19(3):281-5. PubMed ID: 9200768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uremic sera contain inhibitors that block digitoxin-valproic acid interaction.
    Dasgupta A; Paul A; Wells A
    Am J Med Sci; 2001 Oct; 322(4):204-8. PubMed ID: 11678517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of free drug monitoring.
    Dasgupta A
    Clin Chem Lab Med; 2002 Oct; 40(10):986-93. PubMed ID: 12476936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenytoin-oxacillin interactions in normal and uremic sera.
    Dasgupta A; Sperelakis A; Mason A; Dean R
    Pharmacotherapy; 1997; 17(2):375-8. PubMed ID: 9085332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished protein binding capacity of uremic sera for valproate following hemodialysis: role of free fatty acids and uremic compounds.
    Dasgupta A; Jacques M; Malhotra D
    Am J Nephrol; 1996; 16(4):327-33. PubMed ID: 8739287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between valproic acid and carbamazepine: an in vitro study of protein binding.
    Mattson GF; Mattson RH; Cramer JA
    Ther Drug Monit; 1982; 4(2):181-4. PubMed ID: 6808714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of heating human sera at a temperature necessary to deactivate human immunodeficiency virus on measurement of free phenytoin, free valproic acid, and free carbamazepine concentrations.
    Dasgupta A; Wells A; Chow L
    Ther Drug Monit; 1999 Aug; 21(4):421-5. PubMed ID: 10442696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of uremia and hemodialysis on the plasma protein binding of tolmetin.
    Pritchard JF; O'Neill PJ; Affrime MB; Lowenthal DT
    Pharmacology; 1984; 29(6):312-9. PubMed ID: 6505005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid fails to displace phenobarbitone and carbamazepine from plasma protein binding sites in epileptic patients.
    Pisani F; Oteri G; Di Perri R
    Br J Clin Pharmacol; 1981 Jul; 12(1):81-3. PubMed ID: 6788058
    [No Abstract]   [Full Text] [Related]  

  • 15. Competitive binding of ibuprofen and naproxen to bovine serum albumin : modified form of drug-drug displacement interaction at the binding site.
    Rahman MM; Rahman MH; Rahman NN
    Pak J Pharm Sci; 2005 Jan; 18(1):43-7. PubMed ID: 16431382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo plasma protein binding interaction between valproic acid and naproxen.
    Grimaldi R; Lecchini S; Crema F; Perucca E
    Eur J Drug Metab Pharmacokinet; 1984; 9(4):359-63. PubMed ID: 6442704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated free fosphenytoin concentrations in uremic sera: uremic toxins hippuric acid and indoxyl sulfate do not account for the impaired protein binding of fosphenytoin.
    Dasgupta A; Havlik D
    Ther Drug Monit; 1998 Dec; 20(6):658-62. PubMed ID: 9853983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate plasma protein binding in the uremic condition.
    Brewster D; Muir NC
    Clin Pharmacol Ther; 1980 Jan; 27(1):76-82. PubMed ID: 6985855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired protein binding of Chinese medicine DanShen in uremic sera and sera with hyperbilirubinemia: rapid assessment of total and free DanShen concentrations using the fluorescence polarization immunoassay for digoxin.
    Wahed A; Pollard J; Wells A; Dasgupta A
    J Clin Lab Anal; 2003; 17(5):179-83. PubMed ID: 12938147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.